Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Life events or new priorities often require tweaks; identify triggers and implement targeted changes to keep your finances on track.
19,621 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Fox agreed to buy Roku for $22 billion, sending Roku stock to four-year highs and triggering debate over how the deal...
Leaders from the G7 unveiled a plan to shrink reliance on China for rare earths, targeting caps by 2030 and rapid mil...
Rising private valuations for SpaceX are fueling chatter about a Tesla takeover. Market participants say the odds spa...
Roblox shares slid 9% today, pushing the year-to-date drop to roughly 42%. The move came amid broad risk-off trading ...
SoFi started as a fintech lender and evolved into a broader financial platform. This article examines whether could s...
Greece rolls out a four-satellite network that detects fires as small as four meters wide, aiming to cut wildfire los...
The Invesco RAFI Developed Markets ex-US ETF (PXF) has risen about 85.43% in five years while continuing to pay stead...
U.S. regulators move to clear the way for civilian supersonic flights over the continental United States, setting noi...
Tesla reports a robust quarter with deliveries around 515,000, topping expectations and reigniting investor optimism....
Public hearings and local politics are slowing housing supply, hitting renters and buyers with higher costs. This rep...
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...